Venn Life Sciences was an Irish contract research organisation providing clinical development services to pharma and biotech clients, which merged with and rebranded as hVIVO plc in 2017. hVIVO specialises in human challenge studies and early-phase clinical research for infectious diseases and respiratory conditions, operating purpose-built quarantine research facilities in the UK.